Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (309)
- Scheduling (national classification system) (165)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
580 result(s) found, displaying 326 to 350
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the current Poisons Standard in relation to melatonin.
-
Corporate reportsThis Regulation Impact Statement (RIS) is intended to assist the Australian Government in reaching a decision to address the issues relating to the safe use of sports supplements in Australia.
-
Scheduling submissionsPublic submissions on scheduling matters referred to the Joint ACMS-ACCS #25 meetings held in June 2020 - Nicotine
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard referred to the ACMS #31 and Joint ACMS-ACCS #25 meetings held in June 2020
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2019-20
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 13 October 2020
-
Meeting statementsA meeting of the TGACC was held on 27 August 2020. A communique has been published.
-
TGA laboratory testing reportsTGA Laboratories has released a new report describing our assessment of the 2020 seasonal flu vaccine
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the Poisons Standard.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 16 July 2020
-
Scheduling decisions (interim)Invitation for further comment. Closing date: 28 August 2020
-
Corporate reportsThe independent review is complete and the report now published.
-
Corporate reportsFinal Report on the impact of advertising reforms from the Expert Panel Review of Medicines and Medical Devices Regulation, and other initiatives
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsA rapid literature review of safety and performance issues.
-
Scheduling decisions (final)Notice of NCE to be included in Schedule 4 of the Poisons Standard
-
TGA Laboratories testing report: Microbiological testing of medicines containing Green-lipped Mussel
TGA laboratory testing reportsTGA Laboratories Branch has released a report summarising the microbiological testing of green-lipped mussel products -
Corporate reportsThe report card shows the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Meeting statementsAdvisory Committee on Biologicals
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 9 July 2020
-
Meeting statementsCommunique from the meeting of the Therapeutic Goods Advertising Consultative Committee (TGACC).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 19 March 2020